Baibys, a Tel Aviv, Israel-based AI powered fertility startup, reportedly raised $4.5m in Series A funding.
The round was led by Firstime Ventures, with participation from ROHTO.
The company, which has raised a total of $6.5m, intends to use the funds to expand operations, its development efforts and business reach.
Baybys has developed an autonomous sperm selection solution for In-Vitro Fertilization (IVF). It is designed to analyze living sperm cells in real-time using Machine Vision (MV) and Artificial Intelligence (AI). The system evaluates the cells according to morphological criteria, which can only be identified using high magnification. It recognizes structures in motion in order to evaluate the quality of living sperm cells according to previously established criteria using state-of-the-art AI algorithms. The system then autonomously selects and collects the sperm with the highest fertilization potential to microinject into the egg in IVF procedures.
The team includes:
- Itay Itzhaky, Chairman of the Board
- Dr. Yaron Silberman, CEO
- Gal Golov, Co-Founder & Co-CEO
- Dr. Nino Guy Cassuto, Co-Founder & Chief Medical Officer
- Nahum Budin, Sr. VP R&D
- David Rigler, VP Regulatory, Clinical, & Quality Affairs
FinSMEs
12/08/2024